Evidence map›Paper›PMID 39124747›Full record

ArticleJournal of clinical medicine2024

Real-World Adherence and Drug Survival of Biologics among Patients with Ankylosing Spondylitis.

Vered Rosenberg, Howard Amital, Gabriel Chodick, Freddy Faccin, Abdulla Watad, Dennis McGonagle, Omer Gendelman

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vered RosenbergMaccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv 6801296, Israel.ORCID 0000-0002-1535-7091
Howard AmitalFaculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0002-5406-7716
Gabriel ChodickMaccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv 6801296, Israel.ORCID 0000-0002-5189-8995
Freddy FaccinAbbVie Inc., North Chicago, IL 60064, USA.ORCID 0000-0002-3535-7152
Abdulla WatadFaculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0002-1404-8027
Dennis McGonagleLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS9 7JT, UK.ORCID 0000-0001-7715-8226
Omer GendelmanFaculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Funding

AbbVie (United States) No applicable
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adherenceankylosing spondylitisbiological therapydrug survivalreal world

Identifiers

PMID39124747
PMCPMC11313093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.